COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART
- 专利权人:
- Philogen S.P.A.
- 发明人:
- Dario Neri,Hans Menssen,Andreas Menrad,Christoph Schliemann
- 申请号：
- US14306992
- 公开号：
- US20140294723A1
- 申请日:
- 2014.06.17
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- The present invention relates to a combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart and uses thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
- Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
- COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY IL-2 FUSION PROTEIN AND A B-CELL BINDING MOLECULE, B-CELL PROVISIONS AND / OR THEIR CARCINOGENIC COMPOSTER
- Combination of an anti-fibronectin-il-2 edb fusion protein and a b-cell binding molecule, b-cell progenitors and / or their cancerous counterpart
- Combination of a fusion protein of an antibody directed against the fibronectin-IL-2 EDB, and a B-lymphocyte-binding molecule, progenitors of B-lymphocytes and / or their cancerous counterparts
